This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Curevac Ag. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Gregory D. Plowman: Innovator in mRNA Technology
Introduction
Gregory D. Plowman is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of mRNA technology, particularly through his work at CureVac AG. His innovative approach has led to advancements in medical research and therapeutic applications.
Latest Patents
Gregory D. Plowman holds a patent for "KRAS Variant mRNA Molecules." This patent represents a crucial development in the understanding and treatment of certain cancers, showcasing his commitment to improving healthcare through scientific innovation. He has 1 patent to his name, reflecting his focused contributions to the field.
Career Highlights
Throughout his career, Plowman has been dedicated to advancing mRNA technology. His work at CureVac AG has positioned him as a key player in the development of novel therapeutic solutions. His expertise and innovative mindset have been instrumental in driving research forward.
Collaborations
Plowman has collaborated with talented individuals such as Mythili Koneru and Regina Heidenreich. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the potential for groundbreaking discoveries.
Conclusion
Gregory D. Plowman's contributions to mRNA technology and his innovative spirit exemplify the impact of dedicated inventors in the field of medical research. His work continues to inspire advancements that may lead to significant improvements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
